ClinicalTrials.gg

How we know

Every link on this study, and who decided it

The study on the left, the conditions and drugs this site links it to, and on each link the judgments that made or checked it, by day and by judge. The top row is the record itself: each new version seen since tracking began. Dashed lines are links the registry record does not make itself. Select a link to see everything judged on it, or a mark for one decision with its reason and evidence.

11 links0 made here, not in the record21 judgments2 judges (our rules as one)1 record change seen
Model not recordedOur rulesRecord updated on ClinicalTrials.gov
Oct 19Oct 26Nov 2Nov 9Nov 16TodayNCT05008224Study of Safety andEfficacy of Pembrolizumaband Chemotherapy inParticipants With NewlyDiagnosed Classical HodgkinLymphoma (cHL)(MK-3475-C11/KEYNOTE-C11)Merck Sharp & Dohme LLCPhase 2 · completedRECORDThe record itselfVersions seen nightly since Sep 25, 2…›Nov 8 · ClinicalTrials.gov record · MeSH filing re-derivedMeSH filing re-derivedCONDITIONSParkinson Disease 4, Autoso…The registry's MeSH filing›Nov 14 · Our condition-kind rule · MisfiledMisfiledDRUGSPembrolizumabIntervention entry›Nov 1 · A model not recorded · TestedNov 18 · Our role rule · TestedTestedDoxorubicinIntervention entry›Nov 1 · A model not recorded · BackgroundNov 18 · Our role rule · BackgroundBackgroundVinblastineIntervention entry›Nov 1 · A model not recorded · BackgroundNov 18 · Our role rule · BackgroundBackgroundDacarbazineIntervention entry›Nov 1 · A model not recorded · BackgroundNov 18 · Our role rule · BackgroundBackgroundBleomycinIntervention entry›Nov 1 · A model not recorded · BackgroundNov 18 · Our role rule · BackgroundBackgroundEtoposideIntervention entry›Nov 1 · A model not recorded · BackgroundNov 18 · Our role rule · BackgroundBackgroundCyclophosphamideIntervention entry›Nov 1 · A model not recorded · BackgroundNov 18 · Our role rule · BackgroundBackgroundVincristineIntervention entry›Nov 1 · A model not recorded · BackgroundNov 18 · Our role rule · BackgroundBackgroundProcarbazineIntervention entry›Nov 1 · A model not recorded · BackgroundNov 18 · Our role rule · BackgroundBackgroundPrednisoneIntervention entry›Nov 1 · A model not recorded · BackgroundNov 18 · Our role rule · BackgroundBackground

Times are in your time zone; a day marked “day only” kept no time. The graph scrolls sideways on a narrow screen; every mark is also in the list below.

Pembrolizumab

From the registry record2 judgments on this link
Role in the study, from the registry to what was judged
RegistryEntry “Pembrolizumab”the record gives no role
→judged=agrees
How the 2 judgments split100%of judgments with a known value say Tested
Tested · 2

All judgments on this study

WhenLinkJudgeDecisionState
Nov 1PembrolizumabA model not recordedTestedCurrent
Nov 1DoxorubicinA model not recordedBackgroundCurrent
Nov 1VinblastineA model not recordedBackgroundCurrent
Nov 1DacarbazineA model not recordedBackgroundCurrent
Nov 1BleomycinA model not recordedBackgroundCurrent
Nov 1EtoposideA model not recordedBackgroundCurrent
Nov 1CyclophosphamideA model not recordedBackgroundCurrent
Nov 1VincristineA model not recordedBackgroundCurrent
Nov 1ProcarbazineA model not recordedBackgroundCurrent
Nov 1PrednisoneA model not recordedBackgroundCurrent
Nov 8The record itselfClinicalTrials.gov recordMeSH filing re-derivedRecord change
Nov 14Parkinson Disease 4, Autosomal Dominant Lewy BodyOur condition-kind ruleMisfiledCurrent
Nov 18PembrolizumabOur role ruleTestedAgrees
Nov 18DoxorubicinOur role ruleBackgroundAgrees
Nov 18VinblastineOur role ruleBackgroundAgrees
Nov 18DacarbazineOur role ruleBackgroundAgrees
Nov 18BleomycinOur role ruleBackgroundAgrees
Nov 18EtoposideOur role ruleBackgroundAgrees
Nov 18CyclophosphamideOur role ruleBackgroundAgrees
Nov 18VincristineOur role ruleBackgroundAgrees
Nov 18ProcarbazineOur role ruleBackgroundAgrees
Nov 18PrednisoneOur role ruleBackgroundAgrees